$LTBR
LIGHTBRIDGE Corp

2024 Q3 Form 10-Q Financial Statement

#000147793224004507 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.676M $1.793M
YoY Change 4.17% 12.04%
% of Gross Profit
Research & Development $1.299M $909.6K
YoY Change 134.93% 147.95%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.975M $2.702M
YoY Change 37.6% 37.61%
Operating Profit -$2.975M -$2.702M
YoY Change 37.6% 37.61%
Interest Expense $318.7K $327.6K
YoY Change -1.06% 12.96%
% of Operating Profit
Other Income/Expense, Net $318.6K
YoY Change -1.06%
Pretax Income -$2.656M -$2.375M
YoY Change 44.37% 42.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.656M -$2.375M
YoY Change 44.37% 42.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.19 -$0.17
COMMON SHARES
Basic Shares Outstanding 14.60M shares 14.43M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.63M $27.07M
YoY Change -8.9% -4.03%
Cash & Equivalents $26.63M $27.07M
Short-Term Investments
Other Short-Term Assets $403.9K $302.7K
YoY Change 60.03% -14.89%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $27.04M $27.37M
YoY Change -8.31% -4.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $472.9K $476.3K
YoY Change -2.78% -2.76%
Total Long-Term Assets $581.7K $585.1K
YoY Change -2.27% -2.15%
TOTAL ASSETS
Total Short-Term Assets $27.04M $27.37M
Total Long-Term Assets $581.7K $585.1K
Total Assets $27.62M $27.95M
YoY Change -8.19% -4.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.57K $232.8K
YoY Change -21.25% 151.11%
Accrued Expenses $1.100M $700.0K
YoY Change 37.5% 40.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.160M $932.8K
YoY Change 32.43% 57.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.160M $932.8K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.160M $932.8K
YoY Change 32.43% 57.38%
SHAREHOLDERS EQUITY
Retained Earnings -$160.2M -$157.6M
YoY Change 6.81% 6.35%
Common Stock $15.28K $14.59K
YoY Change 18.11% 16.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.46M $27.02M
YoY Change
Total Liabilities & Shareholders Equity $27.62M $27.95M
YoY Change -8.19% -4.13%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$2.656M -$2.375M
YoY Change 44.37% 42.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.944M -$1.847M
YoY Change 71.27% 29.14%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.512M 972.1K
YoY Change -30.38% -38.61%
NET CHANGE
Cash From Operating Activities -1.944M -1.847M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 1.512M 972.1K
Net Change In Cash -432.1K -875.4K
YoY Change -141.71% -673.19%
FREE CASH FLOW
Cash From Operating Activities -$1.944M -$1.847M
Capital Expenditures $0.00
Free Cash Flow -$1.944M
YoY Change 71.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
108865 usd
CY2023Q4 us-gaap Assets
Assets
29397373 usd
us-gaap Share Based Compensation
ShareBasedCompensation
601158 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-240355 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
701506 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3010363 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
302668 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
207063 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
28805508 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
14591 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
184599393 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157591994 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
27021990 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27954822 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29397373 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
486326 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13698 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181295125 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152397776 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
28911047 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2374634 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1672224 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
932832 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
932832 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
us-gaap Interest Income Other
InterestIncomeOther
547814 usd
CY2023Q2 us-gaap Other Income
OtherIncome
291449 usd
us-gaap Other Income
OtherIncome
689575 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2374634 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
476250 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
483000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
108865 usd
CY2024Q2 us-gaap Assets
Assets
27954822 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
486326 usd
CY2024Q2 ltbr Shares Issued Registered Offerings Net Of Offering Costs Amount
SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
982642 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001084554
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
0 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34487
dei Entity Registrant Name
EntityRegistrantName
LIGHTBRIDGE CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1975651
dei Entity Address Address Line1
EntityAddressAddressLine1
11710 Plaza America Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2000
dei Entity Address City Or Town
EntityAddressCityOrTown
Reston
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20190
dei City Area Code
CityAreaCode
571
dei Local Phone Number
LocalPhoneNumber
730-1200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
LTBR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14595928 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27067039 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28598445 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
27369707 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14591477 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13698274 shares
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1792613 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1596818 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3950358 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3462747 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
909612 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
366855 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1933435 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
814899 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2702225 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1963673 usd
us-gaap Operating Expenses
OperatingExpenses
5883793 usd
us-gaap Operating Expenses
OperatingExpenses
4277646 usd
CY2024Q2 ltbr Contributed Services Research And Development
ContributedServicesResearchAndDevelopment
0 usd
CY2023Q2 ltbr Contributed Services Research And Development
ContributedServicesResearchAndDevelopment
0 usd
ltbr Contributed Services Research And Development
ContributedServicesResearchAndDevelopment
0 usd
ltbr Contributed Services Research And Development
ContributedServicesResearchAndDevelopment
31028 usd
CY2024Q2 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
CY2023Q2 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
us-gaap Other Operating Income
OtherOperatingIncome
0 usd
us-gaap Other Operating Income
OtherOperatingIncome
31028 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2702225 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1963673 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5883793 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4246618 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
327591 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
291449 usd
us-gaap Interest Income Other
InterestIncomeOther
689575 usd
CY2024Q2 us-gaap Other Income
OtherIncome
327591 usd
us-gaap Other Income
OtherIncome
547814 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1672224 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5194218 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3698804 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-5194218 usd
us-gaap Net Income Loss
NetIncomeLoss
-3698804 usd
CY2024Q2 ltbr Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.17
CY2023Q2 ltbr Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.14
ltbr Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.38
ltbr Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.32
CY2024Q2 ltbr Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
13930032 shares
CY2023Q2 ltbr Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
11773594 shares
ltbr Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
13710993 shares
ltbr Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
11723941 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29118155 usd
CY2023Q1 ltbr Shares Issued Registered Offerings Net Of Offering Costs Amount
SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
731052 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
215000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
284360 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2026580 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
28321987 usd
CY2023Q2 ltbr Shares Issued Registered Offerings Net Of Offering Costs Amount
SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
1583330 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
15000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
316798 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-1672224 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28564891 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
28911047 usd
CY2024Q1 ltbr Shares Issued Registered Offerings Net Of Offering Costs Amount
SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
1221982 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
255000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
456904 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2819584 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
28025349 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
15000 usd
CY2024Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-10583 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
384216 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-2374634 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
27021990 usd
us-gaap Net Income Loss
NetIncomeLoss
-5194218 usd
us-gaap Net Income Loss
NetIncomeLoss
-3698804 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
15000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
15000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
841120 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-95605 usd
ltbr Increase Decrease In Prepaid Project Costs And Other Long Term Assets
IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
6750 usd
ltbr Increase Decrease In Prepaid Project Costs And Other Long Term Assets
IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
-144750 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
457388 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3725447 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2194041 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2314382 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2194041 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2314382 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1531406 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-695981 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28598445 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28899997 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27067039 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28204016 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7536 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6813 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0454 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0488 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y
CY2024Q2 us-gaap Share Price
SharePrice
2.62
CY2023Q2 us-gaap Share Price
SharePrice
4.31
CY2024Q2 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
100000 usd
CY2023Q2 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
0 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
100000 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
100000 usd
CY2024Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
300000 usd
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
300000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
700000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
500000 usd
CY2024Q2 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
400000 usd
CY2023Q2 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
300000 usd
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
800000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
ltbr Payment Of Accrued Liabilities With Common Stock
PaymentOfAccruedLiabilitiesWithCommonStock
255000 usd
ltbr Payment Of Accrued Liabilities With Common Stock
PaymentOfAccruedLiabilitiesWithCommonStock
215000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company’s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company’s operations will be subject to other numerous contingencies, some of which are beyond management’s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of our nuclear fuel, regulatory approval of the Company’s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company’s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p>
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
600000 usd

Files In Submission

Name View Source Status
0001477932-24-004507-index-headers.html Edgar Link pending
0001477932-24-004507-index.html Edgar Link pending
0001477932-24-004507.txt Edgar Link pending
0001477932-24-004507-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ltbr-20240630.xsd Edgar Link pending
ltbr_10q.htm Edgar Link pending
ltbr_ex311.htm Edgar Link pending
ltbr_ex312.htm Edgar Link pending
ltbr_ex32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ltbr-20240630_cal.xml Edgar Link unprocessable
ltbr-20240630_def.xml Edgar Link unprocessable
ltbr-20240630_lab.xml Edgar Link unprocessable
ltbr-20240630_pre.xml Edgar Link unprocessable
ltbr_10q_htm.xml Edgar Link completed